Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-040983
Filing Date
2023-08-10
Accepted
2023-08-10 08:30:35
Documents
64
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q apvo-20230630.htm   iXBRL 10-Q 2296467
2 EX-31.1 apvo-ex31_1.htm EX-31.1 20390
3 EX-31.2 apvo-ex31_2.htm EX-31.2 20657
4 EX-32.1 apvo-ex32_1.htm EX-32.1 12517
5 EX-32.2 apvo-ex32_2.htm EX-32.2 13409
  Complete submission text file 0000950170-23-040983.txt   8056456

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT apvo-20230630_lab.xml EX-101.LAB 409305
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT apvo-20230630_def.xml EX-101.DEF 201479
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT apvo-20230630_cal.xml EX-101.CAL 34508
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT apvo-20230630.xsd EX-101.SCH 51277
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT apvo-20230630_pre.xml EX-101.PRE 322739
58 EXTRACTED XBRL INSTANCE DOCUMENT apvo-20230630_htm.xml XML 1381768
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

EIN.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37746 | Film No.: 231157336
SIC: 2834 Pharmaceutical Preparations